RAPT Therapeutics logo
RAPT Therapeutics RAPT

Quartalsbericht 2025-Q3
hinzugefügt 06.11.2025

report update icon

RAPT Therapeutics Langfristiger Schuldenstrom 2011-2026 | RAPT

Langfristiger Schuldenstrom Jährlich RAPT Therapeutics

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
2.42 M 2.45 M 2.17 M - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
2.45 M 2.17 M 2.35 M

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
9.96 M $ 22.57 0.04 % $ 3.74 B usaUSA
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
3.55 M $ 1.41 -1.4 % $ 363 M usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
BioNTech SE BioNTech SE
BNTX
45 M $ 91.98 -0.11 % $ 27.2 B germanyGermany
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.56 -3.76 % $ 16.1 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.85 -1.39 % $ 9.26 B australiaAustralia
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 20.87 2.3 % $ 976 M usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
208 K - -2.5 % $ 5.88 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.17 -0.24 % $ 446 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 24.57 -0.16 % $ 3.13 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
7 K - - $ 3.45 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
3.46 M $ 3.17 2.59 % $ 319 M usaUSA
Codiak BioSciences Codiak BioSciences
CDAK
2.66 M - -55.98 % $ 2.15 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Avid Bioservices Avid Bioservices
CDMO
1.35 M - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
1.38 M - - $ 1.41 B usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 2.93 -4.87 % $ 6.38 B israelIsrael
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Celldex Therapeutics Celldex Therapeutics
CLDX
1.55 M $ 33.62 3.73 % $ 2.23 B usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
1.16 M - - $ 401 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Celsion Corporation Celsion Corporation
CLSN
406 K - -6.63 % $ 13.9 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA